• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of age on reporting of adverse clinical events: results from two postmarketing surveillance methods.

作者信息

Bryant S G, Fisher S, Prinsley D M, Olins N J, Larson D B

机构信息

Center for Medication Monitoring, University of Texas Medical Branch, Galveston 77550.

出版信息

Pharmacotherapy. 1991;11(3):249-55.

PMID:1862016
Abstract

Two postmarketing surveillance methods were employed to determine the possible effects of age on reports by outpatients of adverse clinical events (ACEs) occurring shortly after treatment with targeted oral antibiotics or tricyclic antidepressants. One approach involved staff-initiated interviews of patients by telephone and the other involved patient-initiated telephone calls to report possible adverse drug reactions. Regardless of the method, the interviews obtained ACE reports both spontaneously and by review of organ systems. Both postmarketing methods confirmed monotonic relationships for age with treatment duration on the target drugs and with the number of concurrent medications. However, the expected positive correlation between age and spontaneously reported ACEs was evident only in the self-monitoring patients who initiated reports. Negative correlations between age and the number of reported valid ACEs were seen in six independent samples, whereas only two demonstrated a positive relationship. This disparity may elucidate a critical methodologic problem: careful attention must be paid to the means of eliciting information about possible adverse clinical events before attempting to study adverse drug reactions, which are necessarily a subset of ACEs.

摘要

相似文献

1
Effects of age on reporting of adverse clinical events: results from two postmarketing surveillance methods.
Pharmacotherapy. 1991;11(3):249-55.
2
Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people.常用药物的抗胆碱能活性与老年人的神经精神不良事件
J Clin Pharmacol. 2009 Oct;49(10):1176-84. doi: 10.1177/0091270009345690.
3
Reporting of fatal adverse drug reactions.致命药物不良反应的报告。
Can J Clin Pharmacol. 2001 Summer;8(2):84-8.
4
Long-term versus short-term amitriptyline side effects as measured by a postmarketing surveillance system.通过上市后监测系统衡量的阿米替林长期与短期副作用
J Clin Psychopharmacol. 1987 Apr;7(2):78-82.
5
Postmarketing surveillance: accuracy of patient drug attribution judgments.上市后监测:患者药物归因判断的准确性
Clin Pharmacol Ther. 1990 Jul;48(1):102-7. doi: 10.1038/clpt.1990.123.
6
Survey method for post-marketing drug surveillance: a demonstration.上市后药品监测的调查方法:实例演示
J Clin Psychopharmacol. 1988 Jun;8(3):168-76.
7
Postmarketing surveillance by patient self-monitoring: trazodone versus fluoxetine.通过患者自我监测进行上市后监测:曲唑酮与氟西汀对比
J Clin Psychopharmacol. 1993 Aug;13(4):235-42.
8
Safety profile of orlistat: results of a prescription-event monitoring study.奥利司他的安全性概况:一项处方事件监测研究的结果
Int J Obes (Lond). 2006 Nov;30(11):1645-52. doi: 10.1038/sj.ijo.0803323. Epub 2006 Mar 21.
9
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.1969 - 2002年美国药品不良事件监测与药物撤市:报告疑似不良反应的重要性
Arch Intern Med. 2005 Jun 27;165(12):1363-9. doi: 10.1001/archinte.165.12.1363.
10
A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.对3742例加拿大高血压患者进行的喹那普利上市后监测评估:ACCEPT研究。喹那普利加拿大临床评估与患者教育。
Clin Ther. 1994 Sep-Oct;16(5):838-53.